These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29300382)

  • 1. Proposed outcomes measures for state public health genomic programs.
    Doyle DL; Clyne M; Rodriguez JL; Cragun DL; Senier L; Hurst G; Chan K; Chambers DA
    Genet Med; 2018 Sep; 20(9):995-1003. PubMed ID: 29300382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.
    Green RF; Kumerow MT; Rodriguez JL; Addie S; Beachy SH; Senier L
    Public Health Genomics; 2020; 23(5-6):218-229. PubMed ID: 32942283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework.
    Green RF; Ari M; Kolor K; Dotson WD; Bowen S; Habarta N; Rodriguez JL; Richardson LC; Khoury MJ
    Genet Med; 2019 Jan; 21(1):28-37. PubMed ID: 29907802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
    Modell SM; Greendale K; Citrin T; Kardia SL
    Healthcare (Basel); 2016 Jan; 4(1):. PubMed ID: 27417602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
    Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
    Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes.
    Nakonechny QB; Gilks CB
    Surg Pathol Clin; 2016 Jun; 9(2):189-99. PubMed ID: 27241103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories.
    Saam J; Arnell C; Theisen A; Moyes K; Marino I; Roundy KM; Wenstrup RJ
    Oncology; 2015; 89(5):288-93. PubMed ID: 26315041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts.
    Rahm AK; Cragun D; Hunter JE; Epstein MM; Lowery J; Lu CY; Pawloski PA; Sharaf RN; Liang SY; Burnett-Hartman AN; Gudgeon JM; Hao J; Snyder S; Gogoi R; Ladd I; Williams MS
    BMC Health Serv Res; 2018 Oct; 18(1):824. PubMed ID: 30376847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leveraging Implementation Science to Address Health Disparities in Genomic Medicine: Examples from the Field.
    Roberts MC; Mensah GA; Khoury MJ
    Ethn Dis; 2019; 29(Suppl 1):187-192. PubMed ID: 30906168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Singapore Cancer Network (SCAN) Guidelines for Referral for Genetic Evaluation of Common Hereditary Cancer Syndromes.
    Singapore Cancer Network (SCAN) Cancer Genetics Workgroup
    Ann Acad Med Singap; 2015 Oct; 44(10):492-510. PubMed ID: 26763067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blending Insights from Implementation Science and the Social Sciences to Mitigate Inequities in Screening for Hereditary Cancer Syndromes.
    Senier L; McBride CM; Ramsey AT; Bonham VL; Chambers DA
    Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31618814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creation of a network to promote universal screening for Lynch syndrome: the LynchSyndrome Screening Network.
    Mange S; Bellcross C; Cragun D; Duquette D; Gorman L; Hampel H; Jasperson K
    J Genet Couns; 2015 Jun; 24(3):421-7. PubMed ID: 25220566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop.
    Nikolaidis C; Ming C; Pedrazzani C; van der Horst T; Kaiser-Grolimund A; Ademi Z; Bührer-Landolt R; Bürki N; Caiata-Zufferey M; Champion V; Chappuis PO; Kohler C; Erlanger TE; Graffeo R; Hampel H; Heinimann K; Heinzelmann-Schwarz V; Kurzeder C; Monnerat C; Northouse LL; Pagani O; Probst-Hensch N; Rabaglio M; Schoenau E; Sijbrands EJG; Taborelli M; Urech C; Viassolo V; Wieser S; Katapodi MC;
    Public Health Genomics; 2018; 21(3-4):121-132. PubMed ID: 30695780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
    Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
    Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol.
    Morrow A; Hogden E; Kang YJ; Steinberg J; Canfell K; Solomon MJ; Kench JG; Gill AJ; Shaw T; Pachter N; Parkinson B; Wolfenden L; Mitchell G; Macrae F; Tucker K; Taylor N
    Trials; 2019 Jun; 20(1):373. PubMed ID: 31221211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting.
    Bellcross CA; Bedrosian SR; Daniels E; Duquette D; Hampel H; Jasperson K; Joseph DA; Kaye C; Lubin I; Meyer LJ; Reyes M; Scheuner MT; Schully SD; Senter L; Stewart SL; St Pierre J; Westman J; Wise P; Yang VW; Khoury MJ
    Genet Med; 2012 Jan; 14(1):152-62. PubMed ID: 22237445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health equity in the implementation of genomics and precision medicine: A public health imperative.
    Khoury MJ; Bowen S; Dotson WD; Drzymalla E; Green RF; Goldstein R; Kolor K; Liburd LC; Sperling LS; Bunnell R
    Genet Med; 2022 Aug; 24(8):1630-1639. PubMed ID: 35482015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary gynecologic tumors and precision cancer medicine.
    Ogawa C; Hirasawa A; Ida N; Nakamura K; Masuyama H
    J Obstet Gynaecol Res; 2022 May; 48(5):1076-1090. PubMed ID: 35229413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilevel research and the challenges of implementing genomic medicine.
    Khoury MJ; Coates RJ; Fennell ML; Glasgow RE; Scheuner MT; Schully SD; Williams MS; Clauser SB
    J Natl Cancer Inst Monogr; 2012 May; 2012(44):112-20. PubMed ID: 22623603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Colorectal Cancer in Hereditary Syndromes.
    Cunningham LA; Gasior A; Kalady MF
    Surg Oncol Clin N Am; 2022 Apr; 31(2):307-319. PubMed ID: 35351280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.